The September 17 plan buys, line by line
The filing released on September 18 shows a cluster of director and PDMR share acquisitions on September 17 through the company's Employee Share Purchase Plan. Zoran Bogdanovic, the chief executive, bought 126.682 ordinary shares personally and received a company match of 48.472 shares. His euro-normalised filing value was EUR 999,212.19. Anastasios Stamoulis, the chief financial officer, bought 28.157 shares personally and received a company match of 23.043 shares, for a euro-normalised filing value of EUR 71,897.31. Eleven other PDMRs participated in the same plan.
The mechanics matter because this was not a one-off discretionary buy from a lone director trying to catch a dip. It was a broad participation event under an ESPP, and that changes the read. The CEO still matters most, because our scoring weights that role heavily, but the plan structure means you should not confuse broad participation with a single insider making a high-conviction statement about valuation. The filing is still useful. It just needs to be read as a cluster inside a compensation framework, not as a clean, open-market bet.
InsiderTrades data gives this a display score of 48. That score is being pulled by the CEO role, the wide cluster, and the fact that the filing value is tiny relative to the company's market value, under 0.01%. The market cap in the dossier is EUR 19.38bn, so even the largest purchase is not a balance-sheet event. It is a behavior event. Those are different things.
Why the bottler backdrop matters more than the headline buy
Coca-Cola HBC's business sits in a part of the beverage market where the mix is doing more work than the top line headline. Industry reporting has been clear enough on that point. Zero-sugar and functional products are where the category still finds room to grow, while regular CSD volume can remain under pressure. That is not a new story, but it is the one that matters here because CCH is a bottler with exposure to sparkling beverages and energy categories, and recent results have pointed to organic revenue growth and market share gains in those areas.
That matters against PepsiCo because Pepsi has been dealing with a different kind of defensive trade. The U.S. giant has scale, snack exposure, and a broader portfolio, but the market has still been willing to punish it when the growth mix looks less clean. Coca-Cola HBC does not have the same breadth, yet it has a more direct line into the beverage categories the market currently rewards. If you want to know why the stock can sell off hard on a day when insiders are buying, that is the answer. The market is trading the next quarter, not the ESPP.
The macro backdrop does not help either. Inflation remains sticky, energy prices have been a source of pressure, and central banks have stayed tight or signaled more tightening. Global growth forecasts have been nudged lower to around 2.6 to 3.0% for 2026. For a consumer staples name, that is not a disaster, but it does keep pressure on household budgets and on the multiple the market is willing to pay for steady growth. CCH is not being valued in a vacuum. It is being valued against a slower growth world with more expensive money.
What the CEO and CFO bought, and what they did not buy
The CEO's purchase is the one that will get the most attention, and fairly so. Zoran Bogdanovic is the chief executive, and the filing shows EUR 999,212.19 of euro-normalised filing value tied to his participation. That is a real number, and it is large enough to matter in a vacuum. But the context keeps it honest. The shares were acquired through the ESPP at £46.57121 per share on the London Stock Exchange, and the company match was part of the package. This is not the same as a CEO stepping into the market with a personal open-market buy after a selloff.
Anastasios Stamoulis, the CFO, also bought into the same plan. His EUR 71,897.31 filing value is much smaller, but it still matters because finance chiefs usually do not buy for theater. Eleven other PDMRs joined them. That breadth is the more interesting part than the absolute size of any one ticket. A lone insider can be noise. A dozen-plus participants in the same direction is harder to dismiss, even when the plan structure blunts the signal.
The stock reaction complicates the picture in a useful way. If the market had treated the filing as a clean positive, you would expect at least some support. Instead, the shares fell sharply the next day. That tells you the market was focused on something else, or simply did not care about the plan purchase. Either way, the filing did not override the tape. It rarely does on its own.
Our cohort bucket says this is common, not magical
InsiderTrades data places this in the bucket of chief-executive buys at mega-cap names. The historical T+90 cohort for that bucket shows a 46.6% win rate and a -1.16% average return over 90 days, based on 2,048 observations. That is historical cohort data, not a forecast for CCH, and it should be treated that way. The point is not that chief executive buying at mega-cap names fails. The point is that the bucket is mixed, and the average outcome has been modestly negative over the next 90 days.
That is where the comparison with PepsiCo helps again. Large beverage names often trade on a blend of defensiveness and execution, and insider buying in that world tends to be more about alignment than about a sudden edge in timing. If the business is stable and the valuation is not cheap enough to force a rerating, the market can ignore the filing for a while. CCH's 90-day cohort history says you should not overread the purchase as a short-term catalyst. It may still matter as a governance and alignment signal, but the data does not support turning it into a quick-trade thesis by itself.
The same caution applies to the cluster. A wide cluster can be a useful tell when it lines up with a business inflection or a valuation reset. Here, it lines up with an ESPP and a sector that is still trying to prove mix improvement. That is enough to keep the name on the screen. It is not enough to declare the next leg higher.
